Market
What will be the primary use case for the $ZACHXBT memecoin by the end of 2025?
2
Resolution / Starting Odds
Trading and speculation • 25%
Charity and donations • 25%
Community rewards • 25%
Other • 25%
Official announcements from the $ZACHXBT project or ZachXBT
Story
ZachXBT Profits $3.87M from Memecoin on Solana After $20M Hack Recovery
Jan 21, 2025, 11:26 AM
On-chain investigator ZachXBT, known for his work in recovering assets from cryptocurrency hacks, has recently profited from a memecoin created in his likeness on the Solana blockchain. After expressing frustration over not receiving rewards for his efforts in recovering $20 million from a hack, a memecoin named $ZACHXBT was created, with 500M tokens, representing 50% of its supply, sent to ZachXBT's wallet. He added this supply to a liquidity pool, which led to a significant increase in the coin's market cap, surging from $8 million to $80 million within 50 minutes. Subsequently, ZachXBT withdrew approximately 16,059 SOL, valued at around $3.81 million, from the pool. Following this transaction, he transferred 16,348 SOL, worth about $3.87 million, to Wintermute, a trading firm.
View original story
Similar markets
Other • 25%
General transactions • 25%
Charitable donations • 25%
U.S. debt reduction • 25%
Below $10 million • 25%
$10 million to $30 million • 25%
$30 million to $60 million • 25%
Above $60 million • 25%
Medium of exchange • 25%
Store of value • 25%
Other • 25%
Speculative investment • 25%
Other • 25%
Uniswap • 25%
Binance • 25%
Coinbase • 25%
Trading • 25%
Other • 25%
Arbitrage • 25%
Lending • 25%
Speculative Investment • 25%
Payment Method • 25%
Other • 25%
Store of Value • 25%
Establish a Strategic Reserve • 25%
Other • 25%
Hold as an investment • 25%
Sell to reduce national debt • 25%
Positive • 25%
Negative • 25%
Very Positive • 25%
Neutral • 25%
Financial stability reserve • 25%
Other • 25%
International trade settlements • 25%
Monetary policy tool • 25%
Research for Adamantinomatous Craniopharyngioma • 25%
Non-medical purposes • 25%
General brain tumor research • 25%
Other medical research • 25%